The global dextrose injection market is predicted to increase as a result of such widespread engagement in sports

In 2020, the global dextrose injection market is predicted to be worth US$ 9,512.7 million, with a CAGR of 5.7 percent during the forecast period (2020-2027). Because they are chemically equivalent, dextrose and glucose are interchangeable. It is crucial in giving energy to the body's cells. Dextrose injection is a sterile, non-pyrogenic solution for caloric and fluid replenishment. by a single dose. Dextrose injection is given intravenously, that is, directly into a vein. Dextrose injection dosage is determined by the patient's weight, age, and clinical condition. Dextrose 5% in water is injected into a vein to replenish lost fluids and deliver carbs to the body. Hypoglycemia (low blood sugar), insulin shock, and dehydration are all treated with 5% dextrose in water (fluid loss). Dextrose is a type of carbohydrate found in food. The body is nourished by a solution of dextrose, amino acids, and lipids. Total parental nourishment is the term for this. Hyperkalemia is a condition that requires the administration of a 50 percent dextrose solution.



Over the projected period, rising diabetes incidence and diseases linked with diabetes, such as hypoglycemia, are likely to fuel market expansion.

According to a report released by the World Health Organization in June 2020, the number of persons living with diabetes worldwide increased from 108 million in 1980 to 422 million in 2014.

Hypoglycemia is a condition in which the level of blood sugar (glucose) is lower than usual. Hypoglycemia is frequently linked to the treatment of diabetes. According to the Centers for Disease Control and Prevention (CDC), more than 1.5 million persons in the United States suffered from hypoglycemia in 2016.

Furthermore, the Indian government has made a number of sporting initiatives to promote sports among people with disabilities. The National Sports Development Fund Scheme, or ‘Khelo India,' promotes sports among people with disabilities. According to the Khelo India Program, 1,000 students are chosen each year and given a sponsorship of Rs. 5 lakh for an eight-year period. The global dextrose injection market is predicted to increase as a result of such widespread engagement in sports. Dextrose injection is used by athletes to alleviate a range of ligament, muscle, tendon, and joint discomfort.

Global Dextrose Injection Market – Impact of Coronavirus (Covid-19) Pandemic

The COVID-19 virus has spread to over 100 nations since its outbreak in December 2019, prompting the World Health Organization to designate it a public health emergency. As of September 21, 2020, the manifestation of coronavirus illness (COVID-19) had resulted in more than 31 million sick individuals worldwide, according to a World Health Organization report.. Furthermore, in order to combat COVID -19, leading market participants are focused on the launch of unique products. For example, Hikma Pharmaceuticals PLC (Hikma, Group), a multinational pharmaceutical firm, announced the launch of Propofol Injectable Emulsion, USP, 20 mL, 50 mL, and 100 mL vials with 5% dextrose injection in the United States in May 2020 through its US affiliate, Hikma Pharmaceutics, Inc. Propofol injectable emulsion is provided as a ready-to-use formulation. Because it is an emulsion, it should only be diluted with 5 percent Dextrose Injection, USP if dilution is required. It should not be diluted to a concentration less than 2 mg/mL.

Propofol Injectable Emulsion is used in the critical care unit to maintain sedation and anaesthesia in intubated, mechanically ventilated adults. It is currently on the FDA's Drug Shortage List, following a jump in demand caused by the COVID-19 pandemic's increased number of hospitalised, ventilated patients.

Comments

Popular posts from this blog

Continuous Glucose Monitoring (CGM) Devices Market -Dynamics and Forecast

YOU YES YOU!

Key Benefits of Breath Analyzer Market